Objectives:
· Present an overview of the current and near term Digital Therapeutics landscape with a focus on current stages of development.
· Review the impact of COVID-19 as an accelerator for the development and use of Digital Therapeutics.
· Detail real world applications of Digital Therapeutics to illustrate the potential it holds in driving transformation of clinical practices to improve patient outcomes.
· Examine how Medical Affairs can help act as a strategic partner and shape the trajectory of the Digital Therapeutics pipeline and life-cycle.
MODERATOR: Conor Schmitt
Engagement Manager, SSI Strategy
Career management consultant with 7+ years of experience, current focus is on on advising Chief Medical Officers on the development of Medical Affairs functions.
SPEAKER: Jennifer Shannon, MD
Clinical Advisor, Cognoa
Board Certified Child and Adolescent Psychiatrist, Founder of Digital Brain consulting, member of DTA Healthcare Advisory Board
